[Sponsored] The webinar, sponsored by PurpleLab and scheduled for May 22, will explore how healthcare sector companies can leverage real world data (RWD) with a focus on lung cancer. The post Using RWD to Improve Clinical Trial Recruitment, Endpoints, and Inform Market Access Strategies appeared first on MedCity News.
Twenty-two million dollars to repay loans for people working in the addiction field. About $12,000 for gun silencers. Sixteen dollars for a children’s book about Spookley the Square Pumpkin. The purchases varied widely but they all came from the same source: opioid settlement money. The cash, which comes from companies accused of fueling the overdose…
Because of past fraud by rogue brokers, some Affordable Care Act policyholders may get an unexpected tax bill this season. But that isn’t the only potential shock. Other changes coming soon — stemming from proposals by the administration of President Donald Trump — could affect their coverage and its cost. And sorting out related problems…
New research was published this week analyzing how AI can be used to better manage medications for senior patients who use multiple medications simultaneously. It analyzed FeelBetter’s AI platform, which pinpoints patients at high risk of deterioration and preventable hospitalization due to suboptimal medication management. The post AI Can Help Better Manage Polypharmacy Patients, Study…
Between 1999 and 2023, the number of heat-related deaths in the U.S. increased by 117%. KFF analysis of data from the Centers for Disease Control and Prevention shows that American Indian or Alaska Native and Black people are at higher risk of experiencing a heat-related death compared to their White counterparts. Estimates suggest that heat…
KFF Health News editor-at-large for public health Céline Gounder discussed an increase in measles cases in the U.S. on CBS News’ CBS Mornings on Jan. 15. Gounder also discussed a new study on GLP-1 weight loss drugs on CBS News’ CBS News 24/7 and CBS Mornings on Jan. 8. Click here to watch Gounder discuss…
Higher doses of a Viking Therapeutics pill that targets two receptors led to greater weight loss without worsening safety or tolerability, according to Phase 1 results presented during the ObesityWeek conference. Meanwhile, an injectable version of this Viking drug is on track to Phase 3 testing. The post Viking Therapeutics’ Early Clinical Data Continue to…
This ability to closely monitor patients remotely is redefining the standard of care, especially for those managing complex health conditions. RPM technology provides timely insights that allow healthcare teams to intervene early, improve patient outcomes, and reduce the burden on hospital resources. The post How Wearables Are Changing the Way We Monitor Cancer Treatment appeared…
The current wave of generative AI has captured public imagination, but we must temper our expectations. While these models demonstrate impressive capabilities in processing vast amounts of medical literature and generating coherent text, they’re far from perfect. The post Fluency Isn’t Intelligence in Healthcare appeared first on MedCity News.
Joining Matthew Holt (@boltyboy) on #THCBGang on Tuesday November 26 at 1PM PT 4PM ET are THCB regular writer and ponderer of odd juxtapositions Kim Bellard (@kimbbellard); medical historian Mike Magee (@drmikemagee); and a new guest from Marsh McLennan, Employee Benefits Consultant Ryan Koo (@RyanKoo). You can see the video below & if you’d rather listen…